| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | BRISTOL MYERS SQUIBB CO | 200,000 | 10,236,000 | 5.56% | Call | |
| 2 | VALEANT PHARMACEUTICALS INTL | 50,000 | 6,560,000 | 3.56% | Call | |
| 3 | ABBVIE INC | 100,000 | 5,776,000 | 3.14% | Call | |
| 4 | AGILENT TECHNOLOGIES INC | 100,000 | 5,698,000 | 3.09% | Call | |
| 5 | COMMUNITY HEALTH SYS INC NEW COM | 100,000 | 5,479,000 | 2.97% | ||
| 6 | HORIZON PHARMA PLC | 425,000 | 5,219,000 | 2.83% | ||
| 7 | ZIMMER BIOMET HLDGS INC | 50,000 | 5,028,000 | 2.73% | ||
| 8 | WRIGHT MEDICAL GROUP N.V. | 200,000 | 4,780,000 | 2.59% | ||
| 9 | VERTEX PHARMACEUT | 40,000 | 4,492,000 | 2.44% | ||
| 10 | Allergan plc | 25,000 | 4,455,000 | 2.42% | ||
| 11 | CEPHEID | 100,000 | 4,403,000 | 2.39% | Call | |
| 12 | HCA HOLDINGS INC | 60,000 | 4,231,000 | 2.30% | ||
| 13 | MALLINCKRODT PUB LTD CO SHS | 45,000 | 4,057,000 | 2.20% | ||
| 14 | ZELTIQ AESTHETICS INCORPORATED | 175,000 | 3,960,000 | 2.15% | ||
| 15 | INTUITIVE SURGICAL INC | 8,500 | 3,925,000 | 2.13% | ||
| 16 | LIVANOVA PLC | 75,000 | 3,837,000 | 2.08% | ||
| 17 | ARIAD PHARMACEUTICALS INC | 700,000 | 3,780,000 | 2.05% | ||
| 18 | THORATEC LABS CORP | 140,000 | 3,742,000 | 2.03% | ||
| 19 | ATRICURE INC | 250,000 | 3,680,000 | 2.00% | ||
| 20 | ACCURAY INC | 500,000 | 3,630,000 | 1.97% | ||
| 21 | ALLERGAN PLC | 15,000 | 3,619,000 | 1.96% | ||
| 22 | CONCERT PHARMACEUTICALS INC COM | 280,966 | 3,543,000 | 1.92% | ||
| 23 | THERAPEUTICSMD INC | 750,000 | 3,480,000 | 1.89% | ||
| 24 | ENVISION HEALTHCARE HLDGS INC | 100,000 | 3,468,000 | 1.88% | ||
| 25 | ZS PHARMA INC | 85,000 | 3,335,000 | 1.81% | ||
| 26 | VALEANT PHARMACEUTICALS INTL | 25,000 | 3,280,000 | 1.78% | ||
| 27 | NEUROCRINE BIOSCIENCES INC | 200,000 | 3,134,000 | 1.70% | Call | |
| 28 | CLOVIS ONCOLOGY INC | 65,000 | 2,948,000 | 1.60% | ||
| 29 | PORTOLA PHARMACEUTICALS INC | 115,000 | 2,907,000 | 1.58% | ||
| 30 | GW PHARMACEUTICALS PLC | 35,000 | 2,830,000 | 1.54% | ||
| 31 | ALNYLAM PHARMACEUTICALS INC | 35,000 | 2,734,000 | 1.48% | ||
| 32 | QUIDEL CORP COM | 100,000 | 2,687,000 | 1.46% | ||
| 33 | SPECTRANETICS CORP | 100,000 | 2,657,000 | 1.44% | ||
| 34 | BRUKER CORP | 140,000 | 2,592,000 | 1.41% | ||
| 35 | EDWARDS LIFESCIENCES CORP | 25,000 | 2,554,000 | 1.39% | ||
| 36 | EXACT SCIENCES CORP | 125,000 | 2,423,000 | 1.32% | ||
| 37 | CHIMERIX INC | 80,500 | 2,223,000 | 1.21% | ||
| 38 | PTC THERAPEUTICS INC | 50,000 | 2,201,000 | 1.19% | ||
| 39 | ANTARES PHARMA INC | 1,100,000 | 2,013,000 | 1.09% | ||
| 40 | AEGERION PHARMACEUTICALS INC | 60,000 | 2,003,000 | 1.09% | ||
| 41 | MEDTRONIC INC | 30,000 | 1,859,000 | 1.01% | ||
| 42 | DEPOMED INC | 120,000 | 1,823,000 | 0.99% | ||
| 43 | TANDEM DIABETES CARE INC | 131,500 | 1,765,000 | 0.96% | ||
| 44 | NUVASIVE INC COM | 50,000 | 1,744,000 | 0.95% | ||
| 45 | AVALANCHE BIOTECHNOLOGIES IN | 50,000 | 1,710,000 | 0.93% | ||
| 46 | NEUROCRINE BIOSCIE COM USD0.001 | 100,000 | 1,567,000 | 0.85% | ||
| 47 | ACHILLION PHARMACEUTICALS INC | 150,000 | 1,497,000 | 0.81% | Call | |
| 48 | ZAFGEN INC COM | 75,000 | 1,474,000 | 0.80% | ||
| 49 | ENANTA PHARMACEUTICALS INC COM | 35,000 | 1,385,000 | 0.75% | ||
| 50 | ONCOTHYREON INC COM N/C EFF 6/ | 700,000 | 1,344,000 | 0.73% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001164691-14-000217, filed 2014.11.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
